C Arms Devices Market Size was valued at USD 2.2 Billion in 2022. The C Arms Devices market industry is projected to grow from USD 2.32 Billion in 2023 to USD 3.65 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.80% during the forecast period (2023 - 2032). The increasing prevalence of chronic diseases requiring diagnostic imaging and the growing demand for minimally invasive procedures are the key market drivers fueling the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for C arms devices is being driven by the increasing incidence of chronic diseases worldwide. Chronic conditions such as cardiovascular diseases, orthopedic disorders, and cancer often necessitate advanced diagnostic imaging for accurate assessment and timely intervention. C-Arms, with their real-time imaging capabilities, play a crucial role in the diagnosis and monitoring of these conditions. The increasing prevalence of diseases, coupled with the need for precise and immediate imaging for effective treatment planning, has led to a growing demand for C-Arms Devices.
The shift towards minimally invasive procedures across various medical specialties is a key driver fueling the C-Arms Devices market. Minimally invasive surgeries offer patients several advantages, including reduced postoperative pain, shorter recovery times, and lower risk of complications compared to traditional open surgeries. C-arms play a pivotal role in these procedures by providing real-time, high-quality imaging that guides surgeons during interventions.
In fields such as interventional radiology, cardiology, and orthopedics, C-arms are essential for visualizing the internal structures of the body with precision. Procedures like percutaneous coronary interventions, endovascular surgeries, and fluoroscopy-guided orthopedic interventions rely on C-Arms for live imaging, enhancing the surgeon's ability to navigate through anatomical structures with accuracy. The growing preference for minimally invasive techniques, driven by patient demand for quicker recovery and reduced scarring, has increased the adoption of C-Arms Devices across various medical disciplines, contributing to market expansion.
Additionally, continuous advancements in imaging technology have significantly propelled the C-Arms Devices market. Innovations in C-Arm systems, including improvements in image resolution, 3D imaging capabilities, and dose reduction technologies, have enhanced their diagnostic accuracy and safety. The integration of digital flat-panel detectors, advanced image processing algorithms, and ergonomic design features has resulted in more efficient and user-friendly C-Arm devices.
According to the World Health Organization (WHO), chronic diseases account for approximately 71% of all deaths globally. Cardiovascular diseases alone cause 17.9 million deaths each year. The increasing prevalence of chronic conditions underscores the demand for advanced diagnostic tools like C-Arms for timely and accurate assessments. As a result, it is anticipated that throughout the projection period, demand for C C-arm devices will increase due to the rising prevalence of chronic disease. Thus, driving the C Arms Devices market revenue.
The C Arms Devices Market segmentation, based on Type includes Fixed C-Arms and Mobile C-Arms. The mobile C-arms segment dominated the market, accounting for more than half of market revenue. This is linked to their versatility and flexibility. These systems are portable and can be easily maneuvered within different healthcare settings, including operating rooms, emergency departments, and outpatient clinics.
The C Arms Devices Market segmentation, based on Applications includes Cardiology, Gastroenterology, Neurology, Orthopaedics and Trauma, Oncology, and Others. The orthopaedics and trauma segment dominated the market, accounting for above a quarter of market revenue. This is linked to the high prevalence of musculoskeletal conditions and the frequent need for real-time imaging during orthopedic surgeries.
Figure 1: C Arms Devices Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. The North American C Arms Devices market area will dominate this market due to its well-established healthcare infrastructure and the early adoption of advanced medical technologies. The region has a robust network of healthcare facilities, including hospitals and ambulatory surgical centers, which drives the demand for advanced diagnostic and interventional imaging equipment like C-Arms.
Further, the major countries studied in the market report are The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: C ARMS DEVICES MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe C Arms Devices market accounts for the second-largest market share due growing geriatric population and supportive healthcare policies. The aging demographic in Europe has led to a higher incidence of chronic diseases, boosting the demand for diagnostic imaging and interventional procedures facilitated by C-Arms. Further, the German C Arms Devices market held the largest market share, and the UK C Arms Devices market was the fastest-growing market in the European region
The Asia-Pacific C Arms Devices Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to by increasing healthcare investments, a rising burden of chronic diseases, and advancements in healthcare infrastructure. Countries like China and India are making substantial investments in healthcare to meet the growing demand for medical services, including diagnostic imaging. Moreover, China’s C Arms Devices market held the largest market share, and the Indian C Arms Devices market was the fastest-growing market in the Asia-Pacific region.
Leading market players are focusing on continuous research and development to introduce innovative features and technologies in their C-Arm systems, such as improved image quality, reduced radiation dose, and advanced software applications. Market participants are also undertaking a variety of strategic activities to expand their global presence, with important market developments including new product launches, contractual agreements, cost leadership and competitive pricing, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the C Arms Devices industry must offer innovative solutions.
Companies invest in robust after-sales services, including maintenance, training, and customer support. This is one of the key business tactics used by manufacturers in the global C Arms Devices industry to benefit clients and increase the market share. In recent years, the C Arms Devices industry has offered some of the most significant advantages to Consumers. Major players in the C Arms Devices market, including GE Healthcare Inc., Philips Healthcare, Medonica Co., Ltd., Gemss Co. Ltd., Shimadzu Corp., Siemens AG, Hologic Corp., BMI Biomedical International s.r.l., and others, are attempting to increase market demand by investing in product development to increase their product line and cater to diverse consumer needs.
Philips has undergone a significant transformation over the past decade, emerging as a focused leader in health technology. With a purpose centered on improving people's health and well-being through meaningful innovation, the company aims to positively impact 2.5 billion lives annually by 2030, with a specific focus on underserved communities. Philips envisions healthcare as a connected ecosystem, emphasizing preventive care, precise diagnostics, personalized treatment, and seamless patient recovery supported by data integration.
As a technology company, Philips and its brand licensees are dedicated to continuous innovation, driven by the belief that there is always a way to enhance the quality of life through technological advancements. In January 2022, Philips introduced an upgraded 3D image guidance feature in its image-guided therapy mobile C-arms System called Zenition. This improvement is designed to provide better clinical accuracy and efficiency, to enhance outcomes for patients undergoing endovascular treatment.
Siemens, a prominent technology company, specializes in industry, infrastructure, transport, and healthcare solutions. With a commitment to creating technology with purpose, Siemens focuses on resource-efficient factories, resilient supply chains, smart buildings, cleaner transportation, and advanced healthcare, delivering tangible value to its customers. The company leverages the convergence of the real and digital worlds to empower industries and markets, facilitating transformative changes for billions of people worldwide.
Siemens owns a majority stake in Siemens Healthineers, a global leader in medical technology, and a minority stake in Siemens Energy, a key player in electrical power transmission and generation In February 2022, Siemens AG introduced the Artis icono biplane as part of its cardiology portfolio expansion. This advanced system comes with new features for diagnosing and treating conditions like cardiac arrhythmia, coronary heart disease, and structural heart disease. It is designed to streamline clinical workflows and deliver excellent image quality while minimizing radiation exposure.
Key Companies in the C Arms Devices Market Include
C Arms Devices Industry Developments
November 2021: FUJIFILM Healthcare has introduced the Persona CS mobile fluoroscopy system, a compact mobile C-arms imaging solution designed for quick and smooth positioning in operating room (OR) environments.
March 2021: GE Healthcare has received 510(k) clearance from the U.S. FDA for OEC 3D, a recently developed surgical imaging system capable of both 3D and 2D imaging. This product is poised to establish a benchmark for intraoperative 3D imaging, providing precise volumetric images for spine and orthopedic procedures. The new system integrates the advantages and familiarity of 2D imaging with enhanced efficiency, aiming to broaden access and usability for 3D imaging.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 2.2 Billion |
| Market Size 2023 | USD 2.32 Billion |
| Market Size 2032 | USD 3.65 Billion |
| Compound Annual Growth Rate (CAGR) | 5.80% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | GE Healthcare Inc., Philips Healthcare, Medonica Co., Ltd., Gemss Co. Ltd., Shimadzu Corp., Siemens AG, Hologic Corp., BMI Biomedical International s.r.l., and DMS Health Technologies. |
| Key Market Opportunities | ·      Growing Demand for Minimally Invasive Procedures is fueling the market growth |
| Key Market Dynamics | ·      Rising Incidence of Chronic Diseases is driving the market growth |
Frequently Asked Questions (FAQ) :
The C Arms Devices Market size was valued at USD 2.2 Billion in 2022.
The global market is projected to grow at a CAGR of 5.80% during the forecast period, 2023-2032.
North America had the largest share of the global market
The key players in the market are GE Healthcare Inc., Philips Healthcare, Medonica Co., Ltd., Gemss Co. Ltd., Shimadzu Corp., Siemens AG, Hologic Corp., BMI Biomedical International s.r.l., and DMS Health Technologies.
The Mobile C-Arms category dominated the market in 2022.
The Orthopaedics and Trauma had the largest share in the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
